Onglyza Diabetes Drug MDL Sought For Undisclosed Heart Failure Risk
WASHINGTON, D.C. — A plaintiff on Oct. 11 moved to centralize Onglyza/Kombiglyze heart injury lawsuits in a multidistrict litigation and suggested assignment to Judge Jon S. Tigar of the U.S. District...To view the full article, register now.
Already a subscriber? Click here to view full article